Lack of replication of a previously reported association between polymorphism in the 3′UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects

被引:14
作者
Hu, F-Y [1 ,2 ]
Hu, W-B [1 ,3 ]
Liu, L. [1 ]
Yu, L-H [1 ]
Xi, J. [1 ]
He, X-H. [1 ]
Zhu, M-R. [1 ]
Liu, Z-L [4 ]
Xu, Y-M [1 ]
机构
[1] Sichuan Univ, Dept Neurol, W China Hosp, Chengdu 610041, Sichuan, Peoples R China
[2] Yunyang Med Coll, Renmin Hosp, Dept Neurol, Shiyan 442000, Hubei, Peoples R China
[3] Huaguo Hosp, Dept Neurol, Shiyan 442000, Hubei, Peoples R China
[4] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson's disease; Alpha-synuclein; Single nucleotide polymorphism; rs356165; Case-control study; SEQUENCE-ANALYSIS; LEWY BODIES; SUSCEPTIBILITY; POPULATION; HAPLOTYPES; NACP-REP1; GENOTYPE; MUTATION;
D O I
10.1016/j.neulet.2010.05.022
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have implicated polymorphisms in the 3' untranslated region (3'UTR) of the alpha-synuclein (SNCA) gene in the development of Parkinson's disease (PD). Single nucleotide polymorphism (SNP) rs356165 is one of polymorphisms located in the 3'UTR and its association with PD has been reported but remains controversial. Herein, we conducted a case-control study to further evaluate the possible association between SNP rs356165 and PD in Chinese. All subjects (330 PD patients and 300 normal controls) were successfully genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. No statistically significant difference in genotype frequency between cases and controls was observed (P=0.863), suggesting no association of SNP rs356165 with PD in our population. Thus, it may be premature to conclude an association between the 3'UTR of the SNCA gene and PD, and this association should be further examined in different ethnic populations. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 33
页数:3
相关论文
共 24 条
[1]   Caught in the act:: α-synuclein is the culprit in Parkinson's disease [J].
Eriksen, JL ;
Dawson, TM ;
Dickson, DW ;
Petrucelli, L .
NEURON, 2003, 40 (03) :453-456
[2]   Description of Parkinson's disease as a clinical syndrome [J].
Fahn, S .
PARKINSON'S DISEASE: THE LIFE CYCLE OF THE DOPAMINE NEURON, 2003, 991 :1-14
[3]   α-synuclein gene haplotypes are associated with Parkinson's disease [J].
Farrer, M ;
Maraganore, DM ;
Lockhart, P ;
Singleton, A ;
Lesnick, TG ;
de Andrade, M ;
West, A ;
de Silva, R ;
Hardy, J ;
Hernandez, D .
HUMAN MOLECULAR GENETICS, 2001, 10 (17) :1847-1851
[4]   Alpha-synuclein and neurodegenerative diseases [J].
Goedert, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (07) :492-501
[5]   ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES [J].
HUGHES, AJ ;
DANIEL, SE ;
KILFORD, L ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) :181-184
[6]   Genetic studies in Parkinson's disease with an α-synuclein/NACP gene polymorphism in Japan [J].
Izumi, Y ;
Morino, H ;
Oda, M ;
Maruyama, H ;
Udaka, F ;
Kameyama, M ;
Nakamura, S ;
Kawakami, H .
NEUROSCIENCE LETTERS, 2001, 300 (02) :125-127
[7]  
Khan N, 2001, ANN NEUROL, V49, P665
[8]  
Krüger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO
[9]  
2-X
[10]   Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's disease [J].
Mizuta, I ;
Satake, W ;
Nakabayashi, Y ;
Ito, C ;
Suzuki, S ;
Momose, Y ;
Nagai, Y ;
Oka, A ;
Inoko, H ;
Fukae, J ;
Saito, Y ;
Sawabe, M ;
Murayama, S ;
Yamamoto, M ;
Hattori, N ;
Murata, M ;
Toda, T .
HUMAN MOLECULAR GENETICS, 2006, 15 (07) :1151-1158